EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 3.0

Imatinib: A Breakthrough of Targeted Therapy in Cancer

Nida Iqbal iD, Naveed Iqbal

Chemotherapy Research and Practice · 19.05.2014 · 2014 · 1-9

DOI: 10.1155/2014/357027 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemotherapy Research and Practice, erschienen am 19.05.2014. Verfasst von Nida Iqbal und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dr. B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India. Die Arbeit wurde bisher 260-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Deregulated protein tyrosine kinase activity is central to the pathogenesis of human cancers. Targeted therapy in the form of selective tyrosine kinase inhibitors (TKIs) has transformed the approach to management of various cancers and represents a therapeutic breakthrough. Imatinib was one of the first cancer therapies to show the potential for such targeted action. Imatinib, an oral targeted therapy, inhibits tyrosine kinases specifically BCR-ABL, c-KIT, and PDGFRA. Apart from its remarkable success in CML and GIST, Imatinib benefits various other tumors caused by Imatinib-specific abnormalities of PDGFR and c-KIT. Imatinib has also been proven to be effective in steroid-refractory chronic graft-versus-host disease because of its anti-PDGFR action. This paper is a comprehensive review of the role of Imatinib in oncology.

Autor:innen und Institutionen

  • Department of Medical Oncology, Dr. B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India.
  • Department of Anaesthesia and Intensive Care Unit, Indraprastha Apollo Hospital, New Delhi 110076, India.

ORCID-Profile: Nida Iqbal

Zitieren

APA

Iqbal, N., & Iqbal, N. (2014). Imatinib: A Breakthrough of Targeted Therapy in Cancer. Chemotherapy Research and Practice, 2014, 1-9. https://doi.org/10.1155/2014/357027

Vancouver

Iqbal N, Iqbal N. Imatinib: A Breakthrough of Targeted Therapy in Cancer. Chemotherapy Research and Practice. 2014;2014:1-9. doi:10.1155/2014/357027

BibTeX
@article{Iqbal2014,
  author = {Iqbal, Nida and Iqbal, Naveed},
  title = {Imatinib: A Breakthrough of Targeted Therapy in Cancer},
  journal = {Chemotherapy Research and Practice},
  year = {2014},
  volume = {2014},
  pages = {1--9},
  doi = {10.1155/2014/357027}
}
Kostenlos starten →